Skip to main content
TScan Therapeutics, Inc. logo

TScan Therapeutics, Inc. — Investor Relations & Filings

Ticker · TCRX ISIN · US89854M1018 US Professional, scientific and technical activities
Open in API
Filings indexed 310 across all filing types
Latest filing 2021-07-16 Director's Dealing
Country US United States of America
Listing US TCRX

About TScan Therapeutics, Inc.

https://www.tscan.com

TScan Therapeutics, Inc. is a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of cancer. The company's approach is centered on discovering highly effective, naturally occurring TCRs and using them to genetically reprogram T cells. This strategy aims to harness the power of the human immune system to deliver safe and effective immunotherapies to patients.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2021-07-16 English
Regulatory Filings 2021
Regulatory Filings
2021-07-15 English
Regulatory Filings 2021
Regulatory Filings
2021-07-15 English
Regulatory Filings 2021
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the Securities and Exchange Commission (SEC) Division of Corporation Finance, responding to comments on an Amendment No. 4 to a Registration Statement on Form S-1 filed by TScan Therapeutics, Inc. The letter discusses specific details about the company's net tangible book value, share calculations, and disclosure revisions to be made in the Final Prospectus. The presence of the Form S-1 registration statement and the nature of the content indicate this is a regulatory correspondence related to a securities offering registration process, not a financial report or earnings release. The document is a regulatory filing responding to SEC comments, which fits the category of Regulatory Filings (RNS). The document length is about 5,235 characters, and it is a letter rather than a full report or prospectus. Therefore, the appropriate classification is Regulatory Filings (RNS) with high confidence.
2021-07-14 English
Regulatory Filings 2021
Regulatory Filings
2021-07-14 English
8-A12B
Regulatory Filings Classification · 100% confidence The document is a Form 8-A filed with the SEC, which is used for the registration of certain classes of securities pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934. It includes details about the registration of common stock on the Nasdaq Stock Market. The document is a regulatory filing related to securities registration and does not contain financial statements, management discussion, or other report content. It is not an annual report, earnings release, or any other financial or governance report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory documents that do not fit other specific categories.
2021-07-13 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.